AA-24-a was shown to ameliorate nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy in both mouse model and human hepatic stellate cells, and to stimulate autophagy via the AMPK/mTOR/ULK1 pathway [33]. Here, ULK1 is linked to metabolic dysfunction-associated steatohepatitis.